Haixia Cao
Qinghai University Affiliated Hospital(CN)First Affiliated Hospital of Zhengzhou University(CN)Academy of Social Sciences(GB)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Lung Cancer Treatments and Mutations, MicroRNA in disease regulation, Colorectal Cancer Treatments and Studies, RNA modifications and cancer
Most-Cited Works
- → MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel(2015)99 cited
- → Exosome‑mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR‑21(2018)57 cited
- → Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer(2018)53 cited
- → Regulation and functional role of eEF1A2 in pancreatic carcinoma(2009)48 cited
- → PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway(2017)33 cited
- → Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis(2019)32 cited